211 results
8-K
ABT
Abbott Laboratories
29 Jan 24
Entry into a Material Definitive Agreement
4:10pm
for Abbott and its subsidiaries, for which they have received, and may in the future receive, customary compensation and expense reimbursement.
Item … , for which they have received, and may in the future receive, customary compensation and expense reimbursement.
Item 2.03. Creation of a Direct
8-K
EX-99.1
wavfqfs
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
PX14A6G
q4oajy1d41h3w09
4 Apr 23
Letter to shareholders
7:15pm
8-K
EX-3.1
y45x05n o6
9 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
EX-3.1
l2h8vcr
15 Sep 22
Departure of Directors or Certain Officers
4:03pm
8-K
EX-99.1
tzm0ynzo4 vfrf
20 Apr 22
Abbott Reports First-Quarter 2022 Results
7:37am
PX14A6G
16stqjsy2rjw50jdmu
21 Mar 22
Letter to shareholders
2:03pm
8-K
EX-3.1
twdqpi schi7yau3
22 Feb 22
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-99.1
umw2nh
26 Jan 22
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
7:47am
8-K
EX-3.1
8wpvu
10 Dec 21
Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman
4:34pm
8-K
EX-3.1
zfcj2uyasw
1 Sep 21
Departure of Directors or Certain Officers
7:11am